Motus GI Holdings, Inc. (MOTS)
OTCMKTS: MOTS · Delayed Price · USD
0.0600
+0.0100 (20.00%)
Jul 22, 2024, 9:30 AM EDT - Market open
Company Description
Motus GI Holdings, Inc. operates as a medical technology company in the United States.
It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures.
The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016.
The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Motus GI Holdings, Inc.
| Country | United States |
| IPO Date | Feb 14, 2018 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Mark Pomeranz |
Contact Details
Address: 1301 East Broward Boulevard, 3rd Floor Ft. Lauderdale, Florida 33301 United States | |
| Phone | 786-459-1831 |
| Website | motusgi.com |
Stock Details
| Ticker Symbol | MOTS |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001686850 |
| CUSIP Number | 62014P108 |
| ISIN Number | US62014P5044 |
| Employer ID | 81-4042793 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Mark Pomeranz | Non-Independent Director and Chief Executive Officer |
| Ravit Ram | Chief Financial Officer and Vice President of Global Operations |
| Elad Amor | Chief Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 26, 2024 | DEF 14A | Other definitive proxy statements |
| Jun 20, 2024 | 8-K | Current Report |
| Jun 14, 2024 | PRE 14A | Other preliminary proxy statements |
| Jun 7, 2024 | 8-K | Current Report |
| May 14, 2024 | 10-Q | Quarterly Report |
| May 14, 2024 | 8-K | Current Report |
| Apr 25, 2024 | 25-NSE | Filing |
| Apr 11, 2024 | 8-K | Current Report |
| Apr 2, 2024 | EFFECT | Notice of Effectiveness |
| Apr 2, 2024 | 424B3 | Prospectus |